SBIR/STTR Research Award
IgE Peptide Vaccine for Immunotherapy of Allergy
Award amount
$815,016Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- UNITED BIOMEDICAL, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KM1LV5X581A8
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The eventual goal of this program is to develop an IgE peptide-based immunotherapeutic vaccine to treat atopic individuals. The mechanism for this therapy is to generate an anti-lgE antibody response that blocks th
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- LHRH SYNTHETIC PEPTIDE VACCINE FOR PROSTATE CANCER
- LHRH SYNTHETIC PEPTIDE VACCINE FOR PROSTATE CANCER
- PEPTIDE ANTIIGE VACCINE FOR IMMUNOTHERAPY OF ALLERGY
- Oral/Intravaginal Delivery for Chlamydia Vaccine
- SYNTHETIC IGE VACCINE FOR THE TREATMENT OF ALLERGY
Research funding history
7 SBIR/STTR records share this UEI (1991–2004). Reported award amounts total $2,139,034. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services